Iyer et al (72) compared tumor methylation profiles for the tumor suppressor genes APC, FHIT, p15, p16 and CDH1 in tumor tissues and plasma, and found that plasma DNA can be used for the reliable assessment of methylation profiles in HCC patients in an Egyptian population (72). This evidence concerns the gene CDKN2B and hepatocellular carcinoma.